***Background.*** Infective endocarditis (IE) is a serious complication of *Staphylococcus aureus* bacteremia (SAB) that is associated with high morbidity and mortality. There is limited evidence-based guidance on defining which patients with SAB should be screened with echocardiography.

***Methods.*** Risk factors associated with IE in SAB patients were analyzed to identify independent predictors of endocarditis. Clinical data were retrospectively reviewed with follow-up (at least 3-month) data of all adults hospitalized at our institution with SAB from 2006 to 2011. IE was defined using modified Duke\'s Criteria.

***Results.*** Of the 757 patients who were screened, 678 individuals with SAB (24% community-onset, 56% healthcare-associated and 20% nosocomial) met study criteria and were included in the analysis. A total of 85 patients (13%) were diagnosed with definite IE within the 12 weeks of initial presentation. Community onset of SAB, presence of implantable cardiac device, and sustained bacteremia (≥ 72 hours) were identified as independent predictors of SAB from multivariable logistic regression. Two decision rules (Day 1 \[admission day\] and Day 5 \[when results of day 3 blood cultures are known\]) were derived based on the presence of these risk factors, weighted in magnitude by the corresponding regression coefficients, and summed together to define an individual\'s risk score (table). A score of \<2 for Day 1 Rule had a sensitivity of 95.3% and negative predictive value (NPV) of 96.5% whereas a score of \<2 for Day 5 Rule had a sensitivity of 98.8% and negative predictive value (NPV) of 98.5%.

###### 

Test Performance Characteristics of IE Clinical Risk Scores

  Risk Score           Sensitivity   Specificity    PPV     NPV
  ------------------- ------------- ------------- ------- -------
  **Day 1 Score ≥**                                       
  *High Risk* 5           9.4%          99.5%      72.7%   88.5%
   ↑ 4\^                  21.2%         95.6%      40.9%   89.4%
   3                      35.3%         92.4%      40.0%   90.9%
   2\*                    64.7%         70.2%      23.7%   93.3%
   ↓ 1                    95.3%         18.4%      14.3%   96.5%
  *Low Risk* 0            100%          0.0%       12.5%    \-
  **Day 5 Score ≥**                                       
  *High Risk* 7           7.2%          99.7%      75.0%   88.2%
   ↑ 6                    19.3%         97.9%      57.1%   89.4%
   5                      30.1%         96.7%      56.8%   90.6%
   4                      54.2%         83.1%      31.5%   92.7%
   3\*                    86.7%         59.2%      23.4%   96.9%
   2∼                     94.0%         41.1%      18.6%   97.9%
   ↓ 1                    98.8%         11.4%      13.8%   98.5%
  *Low Risk* 0            100%          0.0%       12.5%    \-

***Conclusion.*** We propose clinical decision rules that can accurately classify patients presenting with SAB into a low-risk group that can be managed without cardiac imaging. Larger prospective studies are needed to validate the classification performance of these decision rules.
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